Apellis Pharmaceuticals, Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Apellis Pharmaceuticals, Inc. (APLS)
CIK: 0001492422
Period of Report: 2020-12-31

Reporting Person: Machiels Alec (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-02	Common Stock	G	250000	$0.00	Disposed	419544	Direct
2020-12-02	Common Stock	G	250000	$0.00	Acquired	250000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1950	Indirect

Footnotes

F1: The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.

F2: Owned by the spouse of the reporting person.